Hospice Visit Number Affects Ability to Die at Home
Hospice patients with cancer are more likely to be able to die in the setting of their choice if they receive at least one hospice visit per day during the first four days of hospice care.
Bladder/Kidney/Other Urologic Cancers
ASCO: Anti-PD-1 Antibody Active Against Various Cancers
The anti-programmed death (PD)-1 monoclonal antibody BMS-936558 is active in patients with melanoma, non-small-cell lung cancer (NSCLC), and renal cell cancer that has progressed despite standard therapy.
Pioglitazone Use Ups Bladder Cancer Risk in Type 2 Diabetes
For patients with type 2 diabetes, use of the oral hypoglycemic agent pioglitazone correlates with an increased risk of bladder cancer, with the risk increasing with duration of use.
Selenium and/or Vitamin E Do Not Prevent Bladder Cancer
Neither selenium nor vitamin E alone or used in combination appears to prevent bladder cancer in men.
Folic Acid Enrichment May Reduce Specific Pediatric Cancers
Following mandatory folic acid fortification of enriched grain products in the United States in 1996-1998, there has been a decrease in the incidence of some childhood cancers, including Wilms tumor (WT) and primitive neuroectodermal tumors (PNETs).
Phase 3 Study Update of Tivozanib for First-Line Advanced Renal Cell Carcinoma
AVEO and Astellas announced detailed data from TIVO-1 (Tivozanib Versus Sorafenib in 1st line Advanced Renal Cell Carcionma [RCC]).
Criteria for Surveillance of Small Renal Mass Examined
Active surveillance of patients with small renal masses is driven by a tumor size <3cm, poor performance score (PS), and an endophytic lesion, among other patient, tumor, and surgeon characteristics.
Afinitor Gains Indication for Non-cancerous Kidney Tumors
Novartis announced that the FDA has approved Afinitor (everolimus) tablets for the treatment of adults with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
Bladder Cancer Diagnosis Encourages Smokers to Quit
Smokers with a new diagnosis of bladder cancer are significantly more likely to quit compared with smokers in the general population.
Chemoradiotherapy Combo Ups Bladder Cancer Control
Locoregional control of muscle-invasive bladder cancer is significantly improved with a treatment regimen consisting of radiotherapy and concurrent chemotherapy with mitomycin C and fluorouracil.
